Transforming COPD Care: The impact of exacerbations and hospitalisations in COPD
This is a promotional symposium sponsored and organised by AstraZeneca, intended for GB HCPs only.
COPD burden and the risk of premature mortality
- Uncontrolled COPD might increase the risk of cardiopulmonary events
- Exacerbations as the driving force of all-cause mortality in COPD
- Guidelines on COPD pharmacotherapy
AstraZeneca has provided sponsorship towards this independent Programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence, except for the AstraZeneca sponsored symposia presentations.